Literature DB >> 12623292

The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes.

P Brun1, S Panfilo, D Daga Gordini, R Cortivo, G Abatangelo.   

Abstract

OBJECTIVE: To identify the CD44-receptor-mediated effects of 5-7 x 10(5)MW hyaluronan (HA, Hyalgan) on cell viability in normal and damaged human chondrocyte primary cultures isolated from articular cartilage.
DESIGN: Primary cultures of human chondrocytes were established from normal articular biopsies and expanded to the second culture passage. The dose-response effects of HA on the viability of normal cultures were identified. Chondrocytes were then treated with either hypoxanthine (2 mM) and xanthine oxidase (20-60 mU), or with activated polymorphonuclear leukocytes (PMNs) to induce injury. Damaged and control cells were then treated with 5-7 x 10(5)HA in the previously identified optimal dose of 0.05 mg/ml. Viability was assessed at specific time periods for the chemically and PMN-damaged cells. To identify if HA effects were mediated by the CD44 receptor, chondrocytes were incubated with anti-CD44 antibody at saturating concentrations (5 microg/ml for 100,000 cells) to produce a maximum inhibition of HA binding. Cells were evaluated using the MTT viability assay, histology, electron microscopy and immunohistochemistry.
RESULTS: Direct addition of HA (optimal dose, 0.5 mg/ml) significantly increased cell survival in normal chondrocyte primary cultures (P<0.05). Similarly, addition of this same dose of HA to cultures of free radical-damaged chondrocytes, restored the viability to baseline conditions. Cell viability rates dropped significantly (P<0.05) when CD44 receptor binding was inhibited, indicating that cell growth was mediated by the CD44 receptor.
CONCLUSIONS: HA (0.5 mg/ml of 5-7 x 10(5)) significantly increased the viability of normal human chondrocytes in primary culture and restored cell viability to near normal levels after oxidative cell injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623292     DOI: 10.1016/s1063-4584(02)00352-7

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  16 in total

1.  Joint aging and chondrocyte cell death.

Authors:  Shawn P Grogan; Darryl D D'Lima
Journal:  Int J Clin Rheumtol       Date:  2010-04

2.  Hyaluronan protects bovine articular chondrocytes against cell death induced by bupivacaine at supraphysiologic temperatures.

Authors:  Sen Liu; Qing-Song Zhang; William Hester; Michael J O'Brien; Felix H Savoie; Zongbing You
Journal:  Am J Sports Med       Date:  2012-03-16       Impact factor: 6.202

Review 3.  The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis.

Authors:  Antonio Gigante; Leonardo Callegari
Journal:  Rheumatol Int       Date:  2010-11-28       Impact factor: 2.631

Review 4.  Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective.

Authors:  Mohit Bhandari; Raveendhara R Bannuru; Eric M Babins; Johanne Martel-Pelletier; Moin Khan; Jean-Pierre Raynauld; Renata Frankovich; Deanna Mcleod; Tahira Devji; Mark Phillips; Emil H Schemitsch; Jean-Pierre Pelletier
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-09-12       Impact factor: 5.346

5.  Osteochondral regeneration using a novel aragonite-hyaluronate bi-phasic scaffold in a goat model.

Authors:  E Kon; G Filardo; D Robinson; J A Eisman; A Levy; K Zaslav; J Shani; N Altschuler
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-12       Impact factor: 4.342

6.  Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes.

Authors:  Valentina Grishko; Min Xu; Renee Ho; Aaron Mates; Scott Watson; Jong T Kim; Glenn L Wilson; Albert W Pearsall
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

7.  Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.

Authors:  T Yatabe; S Mochizuki; M Takizawa; M Chijiiwa; A Okada; T Kimura; Y Fujita; H Matsumoto; Y Toyama; Y Okada
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

8.  Characteristics of repair tissue in second-look and third-look biopsies from patients treated with engineered cartilage: relationship to symptomatology and time after implantation.

Authors:  Paola Brun; Sally C Dickinson; Barbara Zavan; Roberta Cortivo; Anthony P Hollander; Giovanni Abatangelo
Journal:  Arthritis Res Ther       Date:  2008-11-11       Impact factor: 5.156

9.  Differences among Branded Hyaluronic Acids in Italy, Part 1: Data from In Vitro and Animal Studies and Instructions for Use.

Authors:  A Migliore; E Bizzi; O De Lucia; A Delle Sedie; M Bentivegna; Asmaa Mahmoud; C Foti
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-05-25

Review 10.  The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review.

Authors:  R D Altman; A Manjoo; A Fierlinger; F Niazi; M Nicholls
Journal:  BMC Musculoskelet Disord       Date:  2015-10-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.